Autoimmune Market Research Reports & Industry Analysis
Classification of autoimmune disorders is still somewhat controversial, but the following criteria is generally accepted: Direct evidence from transfer of pathogenic antibody or pathogenic T cells, indirect evidence based on reproduction of the autoimmune disease in experimental animals, and circumstantial evidence from clinical clues
Arthritis is among the most common autoimmune disorders. Arthritis is joint inflammation The major complaint by individuals who have arthritis is joint pain. Pain is often a constant and may be localized to the joint affected. There are over one hundred forms different forms The most common form, osteoarthritis (degenerative joint disease) is a result of trauma to the joint, infection of the joint, or age. Other arthritis forms are rheumatoid arthritis, psoriatic arthritis, and related autoimmune diseases. Septic arthritis is caused by joint infection. Treatment options vary depending on the type of arthritis and include physical therapy, exercise and weight control, bracing, medications. Surgery may be required in some changes.
Autoimmune Industry Research & Market Reports
-
Systemic Lupus Erythematosus Market Size, Trends, Analysis, and Outlook By Drug Class (NSAIDs, Corticosteroids, Antimalarials, Immunosuppressants, Biologics), By Route of Administration (Oral, Intravenous, Subcutaneous), by Region, Country, Segment, and Companies, 2024-2030
... Erythematosus market size is poised to register 7.07% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Systemic Lupus Erythematosus market across By ... Read More
-
Autologous Cell Therapy Market Size, Trends, Analysis, and Outlook By Therapy , Autologous Stem Cell Therapy, Autologous Cellular Immunotherapies), By Application (Oncology, Musculoskeletal Disorder, Blood Disorder, Autoimmune Disease, Others), By Source (Bone Marrow, Epidermis, Others), By End-User (Hospitals, Research Centers, Others), by Region, Country, Segment, and Companies, 2024-2030
... By End-User (Hospitals, Research Centers, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Autologous Cell Therapy market size is poised to register 18.41% growth from 2024 to 2030, presenting significant growth prospects for ... Read More
-
Immunoassay Market Size, Trends, Analysis, and Outlook By Product (Reagents & Kits, Analyzers Type, Analyzers Purchase Mode), By Technology (ELISA, Chemiluminescence Immunoassay (CLIA), Immunofluorescence assay (IFA), Rapid Tests, ELISpot, Western Blotting, Others), By Specimen (Blood, Saliva, Urine, Others), By Application (Infectious Diseases, Endocrinology, Oncology, Bone & Mineral Disorders, Cardiology, Blood Screening, Autoimmune Disorders, Allergy Diagnostics, Toxicology, Newborn Screening, Others), By End User, Hospitals & Clinics, Clinical Laboratories, Pharmaceutical & Biotechnology Companies and CROs, Blood Banks, Research & Academic Laboratories, Home Care Settings), by Region, Country, Segment, and Companies, 2024-2030
... Saliva, Urine, Others), By Application (Infectious Diseases, Endocrinology, Oncology, Bone & Mineral Disorders, Cardiology, Blood Screening, Autoimmune Disorders, Allergy Diagnostics, Toxicology, Newborn Screening, Others), By End User, Hospitals & Clinics, Clinical Laboratories, Pharmaceutical & Biotechnology ... Read More
-
Implantable Drug Delivery Devices Market Size, Trends, Analysis, and Outlook By Product (Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug Eluting Stents, Bioabsorbable Stents, Intraocular Implants, Infusion Pumps, Others), By Type (Biodegradable, Non-biodegradable), By Technology (Diffusion, Osmotic, Magnetic, Others), By Application (Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases, Others), by Region, Country, Segment, and Companies, 2024-2030
... Osmotic, Magnetic, Others), By Application (Contraception, Ophthalmology, Cardiovascular, Diabetes, Oncology, Autoimmune Diseases, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Implantable Drug Delivery Devices market size is poised to register 8.37% growth from ... Read More
-
Biosimilar Monoclonal Antibodies Market Size, Trends, Analysis, and Outlook By Product (Infliximab, Rituximab, Abciximab, Trastuzumab, Adalimumab, Bevacizumab, Others), By Application (Oncology, Chronic & Autoimmune Diseases, Others), by Region, Country, Segment, and Companies, 2024-2030
... Biosimilar Monoclonal Antibodies market size is poised to register 20.64% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Biosimilar Monoclonal Antibodies market ... Read More
-
Small Molecule CDMO Market Size, Trends, Analysis, and Outlook By Product (Active Pharmaceutical Ingredients (API), Finished Drug Products), By Drug (Innovators, Generics), By Application (Oncology, Cardiovascular Disease, Central Nervous System (CNS) Conditions, Autoimmune/Inflammation, Others), by Region, Country, Segment, and Companies, 2024-2030
... Region, Country, Segment, and Companies, 2024-2030 The global Small Molecule CDMO market size is poised to register 6.17% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry ... Read More
-
Pharmaceutical Market Size, Trends, Analysis, and Outlook By Molecule (Biologics & Biosimilars (Large Molecules), Conventional Drugs (Small Molecules), Pharmaceutical Product, Branded, Generic), By Type (Prescription, OTC, Pharmaceutical Disease, Cardiovascular diseases, Cancer, Diabetes, Infectious diseases, Neurological disorders, Respiratory, Autoimmune, Mental health disorders, Gastrointestinal disorders, Women’s health Diseases, Genetic and rare genetic diseases, Dermatological conditions, Obesity, Renal diseases, Liver conditions, Hematological disorders, Others), By Route of Administration (Oral, Topical, Parenteral, Other), By Formulation (Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Others), By Age group (Children & Adolescents, Adults, Geriatric), By End-user (Hospitals, Clinics, Others), by Region, Country, Segment, and Companies, 2024-2030
... disorders, Respiratory, Autoimmune, Mental health disorders, Gastrointestinal disorders, Women’s health Diseases, Genetic and rare genetic diseases, Dermatological conditions, Obesity, Renal diseases, Liver conditions, Hematological disorders, Others), By Route of Administration (Oral, Topical, Parenteral, Other), By ... Read More
-
Stem Cell Therapy Market Size, Trends, Analysis, and Outlook By Type (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), By Cell Source, Adipose Tissue, Bone Marrow, Placenta/Umbilical Cord, Others), By Therapeutic Application, Musculoskeletal, Wounds, Surgeries, Inflammatory, Autoimmune, Cardiovascular, Others), by Region, Country, Segment, and Companies, 2024-2030
... Inflammatory, Autoimmune, Cardiovascular, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Stem Cell Therapy market size is poised to register 16.8% growth from 2024 to 2030, presenting significant growth prospects for companies operating ... Read More
-
Primary Care POC Diagnostics Market Size, Trends, Analysis, and Outlook By Product (Glucose Testing, Hb1Ac Testing, Autoimmune Disease, Coagulation, Fertility, Infectious Diseases, Cardiac Markers, Thyroid Stimulating Hormone, Hematology, Primary Care Systems, Decentralized Clinical Chemistry, Feces, Lipid Testing, Cancer Marker, Blood Gas/Electrolytes, Ambulatory Chemistry, Drug Abuse Testing, Urinalysis), By End-user (Pharmacy & Retail Clinics, Physician Office, Urgent Care Clinics, Non-practice Clinics), by Region, Country, Segment, and Companies, 2024-2030
... Lipid Testing, Cancer Marker, Blood Gas/Electrolytes, Ambulatory Chemistry, Drug Abuse Testing, Urinalysis), By End-user (Pharmacy & Retail Clinics, Physician Office, Urgent Care Clinics, Non-practice Clinics), by Region, Country, Segment, and Companies, 2024-2030 The global Primary ... Read More
-
Point of Care Diagnostics Market Size, Trends, Analysis, and Outlook By Product(Glucose Testing, Hb1Ac Testing, Coagulation Testing, Fertility/Pregnancy, Infectious Disease , Cardiac Markers, Thyroid, Stimulating Hormone, Hematology, Primary Care Systems, Decentralized Clinical Chemistry, Feces, Lipid Testing, Cancer Marker, Blood Gas/Electrolytes, Ambulatory Chemistry, Drug of Abuser (DOA) Testing, Autoimmune Diseases, Urinalysis/Nephrology), By End user(Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laboratory), by Region, Country, Segment, and Companies, 2024-2030
... Testing, Cancer Marker, Blood Gas/Electrolytes, Ambulatory Chemistry, Drug of Abuser (DOA) Testing, Autoimmune Diseases, Urinalysis/Nephrology), By End user(Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laboratory), by Region, Country, Segment, and Companies, 2024-2030 The global Point ... Read More
-
In vitro Diagnostics Enzymes Market Size, Trends, Analysis, and Outlook By Type (Proteases, Polymerase & Transcriptase, Ribonuclease, Others), By Disease , Infectious disease, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune diseases, Others), By Technology (Histology Assays, Molecular Diagnostics, -PCR Assays, -NGS Assays, -Others), Clinical Chemistry), By End-user (Pharma & Biotech, Hospital & Diagnostic Labs, Contract Research Organizations (CROs), Academic Labs, by Region, Country, Segment, and Companies, 2024-2030
... Diagnostics, -PCR Assays, -NGS Assays, -Others), Clinical Chemistry), By End-user (Pharma & Biotech, Hospital & Diagnostic Labs, Contract Research Organizations (CROs), Academic Labs, by Region, Country, Segment, and Companies, 2024-2030 The global In vitro Diagnostics ... Read More
-
Healthcare Specialty Enzymes Market Size, Trends, Analysis, and Outlook By Product (Carbohydrases, Polymerases and Nucleases, Proteases, Lipases, Phosphatases/Phytases, Others), By Source (Micro-organisms, Animals, Plants), By Technique (Clinical Chemistry, Immunodiagnostics/Immunoassays, Molecular Diagnostics, Hematology, Microbiology), By Usage (Research & Biotechnology, Diagnosis), By Application (Infectious disease, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune diseases), By End-User (Hospitals, Laboratory, Others), by Region, Country, Segment, and Companies, 2024-2030
... (Research & Biotechnology, Diagnosis), By Application (Infectious disease, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune diseases), By End-User (Hospitals, Laboratory, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Healthcare Specialty Enzymes market size is poised ... Read More
-
The 2025-2030 World Outlook for Therapeutic Plasma Exchange for Neurological Disorders
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2025-2030 World Outlook for Lupus Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Intravenous Immunoglobulin for Guillain-Barre Syndromes
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Primary Immunodeficiency
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Primary Immunodeficiency Diseases
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Subcutaneous Immunoglobulins
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Guillain-Barre Syndrome Therapeutics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Systemic Lupus Erythematosus (SLE) Drugs
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Systematic Lupus Erythematosus Treatments
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Autoimmune Disorder Diagnostics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Immunoglobulins
... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More
-
The 2025-2030 World Outlook for Anti-Inflammatory Lupus Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Autoimmune Disease Diagnostic Consumables and Assay Kits
... estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. ... Read More
Research Assistance
